Prothena to put off majority of workers; Zealand shares weight problems drug information

Prothena will lower 63% of its workforce and consider a “vary of enterprise choices.” Elsewhere, Zealand revealed information for a dual-acting weight problems drug and Biogen kicked off a brand new late-stage trial.